Vignette Bio Overview
- Year Founded
-
2023
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$370M
Vignette Bio General Information
Description
Developer of novel therapies designed to address immunology and inflammation-associated diseases. The company is currently operating in stealth mode.
Contact Information
Website
www.vignettebio.com(Operating Subsidiary)
Corporate Office
- 11622 El Camino Real
- Suite 150
- San Diego, CA 92130
- United States
Corporate Office
- 11622 El Camino Real
- Suite 150
- San Diego, CA 92130
- United States
Vignette Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 19-Aug-2024 | $370M | Completed | Stealth | ||
| 1. Early Stage VC (Series A) | 07-Aug-2024 | Completed | Stealth |
Vignette Bio Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Foresite Capital | Growth/Expansion | Minority | ||
| Mirae Asset Capital Life Science | Venture Capital | Minority | ||
| Qiming Venture Partners | Venture Capital | Minority | ||
| Samsara BioCapital | Venture Capital | Minority |
Vignette Bio FAQs
-
When was Vignette Bio founded?
Vignette Bio was founded in 2023.
-
Where is Vignette Bio headquartered?
Vignette Bio is headquartered in San Diego, CA.
-
What industry is Vignette Bio in?
Vignette Bio’s primary industry is Drug Discovery.
-
Is Vignette Bio a private or public company?
Vignette Bio is a Private company.
-
What is the current valuation of Vignette Bio?
The current valuation of Vignette Bio is .
-
What is Vignette Bio’s current revenue?
The current revenue for Vignette Bio is .
-
How much funding has Vignette Bio raised over time?
Vignette Bio has raised $105M.
-
Who are Vignette Bio’s investors?
Foresite Capital, Mirae Asset Capital Life Science, Qiming Venture Partners, and Samsara BioCapital have invested in Vignette Bio.
-
When was Vignette Bio acquired?
Vignette Bio was acquired on 19-Aug-2024.
-
Who acquired Vignette Bio?
Vignette Bio was acquired by Candid Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process